logo
  • About us
    • The Company in brief
    • Strategy
    • Market
    • Organisation
      • Management
      • Board of Directors
  • Our Drug Projects
    • Science
    • Pipeline
    • Disorders
      • Primary Biliary Cholangitis (PBC)
      • Hepatic Encephalopathy (HE)
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • General meetings
    • Calendar
    • Press Releases
  • Media
    • Press Releases
    • Subscribe
  • Contact

Annual General Meeting 2024

May 28, 2024

The annual general meeting of 2024 was held on Tuesday May 28, 2024.

Documents

  • Notice to attend AGM 2024
    April 30, 2024 English
  • Kallelse till årsstämma 2024
    April 30, 2024 Swedish
  • Power Of Attorney Form and Voting Instruction
    English
  • Fullmaktsformulär och röstinstruktion
    Swedish
  • Power of attorney for
    English
  • Fullmaktsformulär
    Swedish
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
    • General meetings
    • Calendar
    • Press Releases

CONTACT

Viktor Drvota
CEO and Chairman of the Board
Phone +46 8-524 860 70
[email protected]

All contacts

VISITING ADDRESS

Umecrine Cognition AB
Karolinska Institutet Science Park
Nanna Svartz väg 6A,
171 65 Solna
Sweden

COMPANY INFORMATION

Umecrine Cognition AB
Registered office in Umeå
Reg no 556698-3655

  • Cookies
  • Privacy Policy